Comments out of SLA AGM - BPO maybe further down the track than letting on, in possible testing/application of Bio A in equine [Thoroughbred/Racing] Middle East use, where horses are stabled indoors which frequently leads to bowel disorders & stomach ulcers. A rumored of a treatment trial was floated several months back after a Saudi "client approach" for this Bio A application. I have no idea how efficacy on animal applications works in that part of the world - but the product already has a good track record and early traction in such a lucrative arena would be good news.
BPO Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
